ELAB
NASDAQ
$1.05
PMGC Holdings Inc (ELAB)
Elevai Labs, Inc. (Ticker: ELAB) is an innovative technology firm at the forefront of artificial intelligence and machine learning, primarily catering to the healthcare and finance sectors. By leveraging sophisticated data analytics, the company empowers organizations to extract actionable insights from intricate datasets, thus enhancing operational efficiencies and supporting strategic decision-making. Positioned strategically within a dynamic technology landscape, Elevai Labs is well-prepared to harness emerging market trends for growth, underscoring its commitment to advancing AI technologies and solidifying its role as a significant player with strong potential for sustainable development and competitive advantage.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$221K
P/B Ratio
0.40
Price Chart
Valuation
Market Cap$221K
P/S5.26
P/B0.40
Profitability
Total Revenue (TTM)-$1.46M
Gross Profit (TTM)-$803K
EBITDA-$6.12M
Operating Margin-752%
EPS-$58.56
Financial Health
Debt-to-Equity37.6%
Growth & Risk
Sharpe Ratio-1.06